What is Openwater?
Founded in 2016, Openwater is at the forefront of a revolutionary approach to healthcare, aiming to integrate advancements in consumer electronics, semiconductor device physics, and artificial intelligence. The company's core mission is to make the curing of diseases a widespread reality, transcending geographical limitations and fundamentally transforming human health outcomes. Openwater's vision centers on a single device capable of treating a vast spectrum of conditions, including cancer, mental and neurodegenerative diseases, and stem cell stimulation, alongside hundreds of other ailments. This ambitious undertaking positions Openwater as a key innovator in the medtech sector, leveraging cutting-edge technology for broad therapeutic applications.
How much funding has Openwater raised?
Openwater has raised a total of $100M across 1 funding round:
Other Financing Round
$100M
Other Financing Round (2024): $100M with participation from BOLD Capital Partners and Khosla Ventures
Key Investors in Openwater
BOLD Capital Partners
BOLD Capital Partners is a venture capital firm dedicated to investing in entrepreneurs and technologies that aim to transform the world. They focus on identifying emerging science and technologies that can disrupt and democratize large markets, addressing significant challenges faced by humanity. The firm collaborates with a diverse team of professionals, including entrepreneurs, engineers, and scientists, to support innovative solutions. Their portfolio includes companies that leverage advancements in various fields, such as artificial intelligence and gene editing, to redefine industries and improve lives.
Khosla Ventures
Khosla Ventures is a prominent venture capital firm known for its investments in a wide range of technology sectors, often focusing on disruptive innovations and early-stage companies. They are recognized for backing ambitious projects that have the potential to reshape industries and address significant global challenges, aligning well with Openwater's transformative mission in healthcare.
What's next for Openwater?
The substantial enterprise-level funding and recent strategic investment signal a critical growth phase for Openwater. This capital infusion is expected to accelerate the development and deployment of its groundbreaking medical device. The company is likely to focus on scaling its operations, expanding its research and development capabilities, and navigating the complex regulatory pathways required for medical technologies. The involvement of sophisticated investors like BOLD Capital Partners and Khosla Ventures suggests a strategic roadmap focused on market penetration and achieving Openwater's ambitious goal of transforming global health.
See full Openwater company page
